Search results
Results from the WOW.Com Content Network
Not all cancer biomarkers have to be specific to types of cancer. Some biomarkers found in the circulatory system can be used to determine an abnormal growth of cells present in the body. All these types of biomarkers can be identified through diagnostic blood tests, which is one of the main reasons to get regularly health tested.
Each assay may give different results of the clinical value of the p53 mutations as a prognostic factor. [5] Interlaboratory proficiency testing for tumor marker tests, and for clinical tests more generally, is routine in Europe and an emerging field [6] in the United States. New York state is prominent in advocating such research. [7]
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology.Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in ...
Cancer is a disease with excessive molecular causes and constant evolution. There's also heterogeneity of disease even in an individual. Molecular studies of cancer have proved the significance of driver mutations in the growth and metastasis of tumors. [46] Many technologies for detection of sequence variations have been developed for cancer ...
In recent years, advances in molecular techniques, genomics, cancer biology and sequencing technology have provided opportunities to discover and validate new biomarkers for prognosis, particularly molecular prognostic markers.
Genetic Testing and Molecular Biomarkers is a monthly peer reviewed scientific journal published by Mary Ann Liebert, Inc. The editor-in-chief is Garth Ehrlichs.The journal covers genetic testing research along with associated ethical, legal, social, and economic issues.
Biomarkers is a peer-reviewed academic journal covering research on biomarkers. It is published by Taylor & Francis and the editor-in-chief is Martin Möckel ( Charité ). According to the Journal Citation Reports , the journal has a 2015 impact factor of 2.016.
Biomarker discovery is a medical term describing the process by which biomarkers are discovered. Many commonly used blood tests in medicine are biomarkers. There is interest in biomarker discovery on the part of the pharmaceutical industry; blood-test or other biomarkers could serve as intermediate markers of disease in clinical trials, and as possible drug targets.